Cerevel Drug Hunters

The first podcast features Dr. Rick Briscoe, Senior Vice President, Safety Assessment and Research Operations, discussing his journey, aspirations, and personal motivation for developing new solutions for people living with neuroscience diseases.

On this episode of Drug Hunters, Dr. John Renger interviews his executive assistant, Kristen Larrabee. Kristen recounts her early days as an assistant in various industries, and what led her to join Cerevel. She describes candidly what it’s like to support Dr. John Renger, and his larger organization, with some creative strategies. Enjoy!

On the next episode of Drug Hunters, Dr. John Renger sits down with Cerevel’s Senior Director of Research Operations, Dr. Kim Kerr. Kim takes us through her group’s mission to support the scientists in what they do; science! We get a closer inside look at how her team acts as the operational glue for the CSO organization in providing nonclinical project management support, program management support for early programs and beyond, lab infrastructure, Environmental Health and Safety and Facilities.

On this episode of Cerevel Drug Hunters, Dr. John Renger interviews Dr. Srinivas Chakilam, Vice President, Drug Metabolism and Pharmacokinetics (DMPK). We get an inside look into what Srinivas and his team do at Cerevel to uncover and understand molecule properties from the research stage all the way to filing NDAs (New Drug Applications). They help to unravel how the drug is metabolized and what it does to the body to glean efficacy information.

On the next episode of Drug Hunters, Dr. John Renger interviews two members from CereVets, Cerevel’s newly launched Veteran Employee Resource Group. The episode features Jack Homsher VP, Human Resources (former Senior Chief, and SEAL, US Navy), and Francisco Guzman, Principal Scientist, Process Development (former First-class Petty Officer, US Navy). Listen to learn about this group’s important mission within Cerevel. You can also hear first-hand what it’s been like for Jack and Francisco to transition from the US Navy into the Cambridge, MA, biopharmaceuticals world where they are now using their experiences and skillsets to combat neuroscience diseases!